Recurrent Ependymal Tumor
1 clinical trials · Condition
◉ Watch Recurrent Ependymal Tumor
| Record | Firm | Date |
|---|---|---|
| Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) (NCT03698994) | National Cancer Institute (NCI) | 2018-11-14 |
Track Recurrent Ependymal Tumor automatically
Every clearance here is in the API, with alerts when new ones post.